Psychedelics have shown promise as treatments in clinical settings, but there remains work to be done to develop the next generation of psychedelic and plant-based medicines. That’s a problem that Montreal-based Opportune Therapeutics is working to solve for the psychedelic and plant-based medicine segment. The company, which has a background in pharmaceutical and biotech, is using machine…